首页> 中国专利> 雷公藤甲素在制备治疗肾小球足细胞疾病的药物中的应用

雷公藤甲素在制备治疗肾小球足细胞疾病的药物中的应用

页面导航

摘要
著录项
法律信息
相似文献

摘要

一种雷公藤甲素的用途，它可以用于治疗肾小球足细胞疾病。它可以抑制肾小球足细胞的损伤，显著降低肾小球足细胞疾病中蛋白尿的产生，因此可以用于制备治疗肾小球足细胞疾病的药物。

著录项

公开/公告号CN101032480A

专利类型发明专利
公开/公告日2007-09-12

原文格式PDF
申请/专利权人中国人民解放军肾脏病研究所;
展开▼

申请/专利号CN200610040816.2
发明设计人刘志红;黎磊石;
展开▼

申请日2006-07-27
分类号A61K31/365;A61P13/12;
代理机构南京知识律师事务所;
代理人黄嘉栋
地址 210002 江苏省南京市中山东路305号
入库时间 2023-12-17 19:07:33

法律信息

法律状态公告日

法律状态信息

法律状态
2010-07-21

发明专利申请公布后的视为撤回 IPC(主分类):A61K31/365 公开日:20070912 申请日:20060727

发明专利申请公布后的视为撤回
2007-11-07

实质审查的生效

实质审查的生效
2007-09-12

公开

公开

相似文献

专利
中文文献
外文文献

1. 雷公藤甲素在制备治疗肾小球足细胞疾病的药物中的应用 [P] . 中国专利： CN101032480A . 2007-09-12
2. 苍术、厚朴及苍术与厚朴配伍在制备预防和治疗足细胞损伤型肾小球疾病的药物中的用途 [P] . 中国专利： CN113181227A . 2021-07-30
3. Application of a prolactin inhibitor compound to prepare a medicine for the treatment of an immune system dysfunction application of a prolactin stimulating compound to prepare a medicine for the treatment of an immune system dysfunction application of a prolactin stimulating compound to prepare a medicine for the treatment of an autoimmune disease and therapeutic package [P] . BR9507858A . 1997-11-04

机译：催乳激素抑制剂化合物在制备用于治疗免疫系统功能障碍的药物中的应用催乳激素刺激化合物在制备用于治疗免疫系统功能障碍的药物中的应用催乳激素刺激化合物在制备用于治疗免疫系统功能障碍的药物中的应用自身免疫性疾病和治疗方案
4. composition, pharmaceutical composition, effervescent dosage form, multiple unit oral oral pharmaceutical composition, extended release pharmaceutical dosage form, enteric coated pharmaceutical dosage form, stable pharmaceutical dosage form for oral administration to mammalian subjects, method for treating diseases acid-related diseases by inhibiting gastric acid secretion, method for treating a bacterial infection caused or caused by helicobacter pylori, process for preparing a compound of formula 3, process for preparing a compound of formula 5, use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion, use of a compound of formula 1 for the preparation of a medicament for treating a bacterial infection caused or caused by helicobacter pyl or use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion [P] . BRPI0617987A2 . 2011-08-16

机译：组合物，药物组合物，泡腾剂型，多单位口服口服药物组合物，缓释药物剂型，肠溶衣药物剂型，向哺乳动物受试者口服给药的稳定药物剂型，通过抑制胃酸治疗疾病的方法酸分泌，治疗由幽门螺杆菌引起或引起的细菌感染的方法，制备式3化合物的方法，制备式5化合物的方法，式1化合物在制备用于治疗胃的药物中的用途通过抑制胃酸分泌来治疗与酸有关的疾病，将式1的化合物用于制备用于治疗由幽门螺杆菌引起或引起的细菌感染的药物，或将式1的化合物用于制备用于治疗的药物通过抑制胃酸分泌来治疗胃酸相关疾病
5. Medicament for the prevention and / or treatment of atherosclerosis, medicaments for inhibiting vascular smooth muscle cell proliferation, neointimal formation of blood vessels and vascular remodeling, medicament for the prevention of restenosis following percutaneous coronary intervention, and, medicines for the prophylaxis and / or treatment of hypertension or diseases caused by hypertension or diseases caused by hypertension, heart disease, angina pectoris, myocardial infarction, arrhythmia, sudden death, heart failure, cardiac hypertrophy, kidney diseases, diabetic nephropathy, glomerulonephritis, nephrosclerosis, cerebrovascular diseases, cerebral infarction, and cerebral hemorrhage [P] . BRPI0406987A . 2006-01-10

机译：用于预防和/或治疗动脉粥样硬化的药物，用于抑制血管平滑肌细胞增殖，血管新生内膜形成和血管重塑的药物，用于经皮冠状动脉介入治疗后预防再狭窄的药物，以及用于预防和/或治疗的药物高血压或由高血压引起的疾病或由高血压，心脏病，心绞痛，心肌梗塞，心律不齐，猝死，心力衰竭，心脏肥大，肾脏疾病，糖尿病肾病，肾小球肾炎，肾硬化，脑血管疾病，脑梗死和脑出血